Last updated: May 29, 2026

Application No. 17/640,864

Therapeutic Methods And Uses Thereof

Non-Final OA

Filed

Mar 07, 2022

Priority

Aug 23, 2019 — AU 2019903095 +1 more

Examiner

TRAN, ERIC

Art Unit

1629

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Eustralis Pharmaceuticals Limited (Trading AS Pressura Neuro)

OA Round

3 (Non-Final)

Interview Optional

— +24.7% interview lift. Examiner has a relatively high allowance rate (69%); +24.7% interview lift. A written response may suffice.

Based on 99 resolved cases, 2023–2026

Examiner Intelligence

TRAN, ERIC View full profile →

Grants 69% — above average

Career Allowance Rate

68 granted / 99 resolved

+8.7% vs TC avg

Strong +25% interview lift

Without

With

+24.7%

Interview Lift

resolved cases with interview

Typical timeline

2y 9m

Avg Prosecution

22 currently pending

Career history

133

Total Applications

across all art units

Statute-Specific Performance

§101

2.1%

-37.9% vs TC avg

§103

41.7%

+1.7% vs TC avg

§102

12.3%

-27.7% vs TC avg

§112

16.2%

-23.8% vs TC avg

Black line = Tech Center average estimate • Based on career data from 99 resolved cases

Prosecution Timeline

Mar 07, 2022

Application Filed

Mar 20, 2025

Non-Final Rejection mailed

Jun 20, 2025

Response Filed

Sep 19, 2025

Final Rejection mailed

Feb 19, 2026

Request for Continued Examination

Feb 25, 2026

Response after Non-Final Action

Apr 23, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

16/831,399

Patent 12636288

METHODS AND COMPOSITIONS FOR TREATING PULMONARY HYPERTENSION

6y 2m to grant Granted May 26, 2026

17/788,393

Patent 12637440

NOVEL AMIDE DERIVATIVE USEFUL AS DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITOR, AND USE THEREOF

3y 11m to grant Granted May 26, 2026

17/279,705

Patent 12622895

ANTI-NEURODEGENERATIVE COMBINATIONS AND USE FOR TREATMENT OF NEURODEGENERATIVE DISEASES

5y 1m to grant Granted May 12, 2026

19/094,187

Patent 12617783

HETEROCYCLIC GLP-1R AGONISTS

1y 1m to grant Granted May 05, 2026

19/100,372

Patent 12606578

CRYSTAL FORM OF SPIROCYCLIC AMINE ARYL PHOSPHORUS OXIDE COMPOUND AND PREPARATION METHOD THEREFOR

10m to grant Granted Apr 21, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4

Expected OA Rounds

69%

Grant Probability

93%

With Interview (+24.7%)

2y 9m (~0m remaining)

Median Time to Grant

High

PTA Risk

Based on 99 resolved cases by this examiner. Grant probability derived from career allowance rate.